Turan A.Karamanlio?lu B.Memiş D.Pamukçu Z.2024-06-122024-06-1220030265-0215https://doi.org/10.1017/S0265021503260300https://hdl.handle.net/20.500.14551/16199[No abstract available]en10.1017/S0265021503260300info:eu-repo/semantics/closedAccessAntiinflammatory Agent; Atracurium; Atropine; Bradykinin; Glyceryl Trinitrate; Kallikrein Inhibitor; Kininogen; Midazolam; Placebo; Propofol; Sevoflurane; Vasodilator Agent; Adult; Allergic Reaction; Anesthesia; Anesthesia Induction; Anesthesist; Angina Pectoris; Clinical Trial; Controlled Clinical Trial; Controlled Study; Dose Response; Drug Effect; Female; Human; Injection Pain; Letter; Major Clinical Study; Male; Muscle Relaxation; Pain Assessment; Phlebitis; Randomized Controlled Trial; Treatment Outcome; Administration, Cutaneous; Anesthetics, Intravenous; Female; Humans; Male; Middle Aged; Nitroglycerin; Pain; Propofol; Vasodilator AgentsAlternative application site of transdermal nitroglycerin and the reduction of pain on propofol injection [6]Letter2021701722-s2.0-003732113512622508Q1